Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Asher

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
The Israel Medical Association Journal : IMAJ|September 24, 2015
Granulomatous Lobular MastitisKeren Mahlab-Guri, Ilan Asher, Tanir Allweis, et al.
Thrombosis Research|October 27, 2009
Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injuryDeborah Rubin-Asher, Gabriel Zeilig, Aba Ratner, et al.
Human Immunology|March 13, 2009
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patientsZev M Sthoeger, Amir Sharabi, Molly Dayan, et al.
Journal of Autoimmunity|April 7, 2009
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expressionZev M Sthoeger, Amir Sharabi, Yair Molad, et al.
Medicine|November 29, 2016
Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patientsKeren Mahlab-Guri, Ilan Asher, Shira Rosenberg-Bezalel, et al.
Harefuah|December 25, 2013
[Allergy to drugs and contrast media--recommendations of the Israeli Allergy and Clinical Immunology Association]Nancy Agmon-Levin, Yuval Tal, Arnon Broides, et al.
International Journal of STD & AIDS|December 20, 2013
Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in IsraelDaniel Elbirt, Ilan Asher, Keren Mahlev-Guri, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 23, 2011
Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with RitonavirKeren Mahlab-Guri, Ilan Asher, Serge Gradstein, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2018
The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patientsZev Sthoeger, Amir Sharabi, Ilan Asher, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 5, 2021
Characteristics of patients with spontaneous resolution of sesame allergyKeren Mahlab-Guri, Alex Guri, Laliv Kadar, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
The Israel Medical Association Journal : IMAJ|September 24, 2015
Granulomatous Lobular MastitisKeren Mahlab-Guri, Ilan Asher, Tanir Allweis, et al.
Thrombosis Research|October 27, 2009
Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injuryDeborah Rubin-Asher, Gabriel Zeilig, Aba Ratner, et al.
Human Immunology|March 13, 2009
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patientsZev M Sthoeger, Amir Sharabi, Molly Dayan, et al.
Journal of Autoimmunity|April 7, 2009
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expressionZev M Sthoeger, Amir Sharabi, Yair Molad, et al.
Medicine|November 29, 2016
Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patientsKeren Mahlab-Guri, Ilan Asher, Shira Rosenberg-Bezalel, et al.
Harefuah|December 25, 2013
[Allergy to drugs and contrast media--recommendations of the Israeli Allergy and Clinical Immunology Association]Nancy Agmon-Levin, Yuval Tal, Arnon Broides, et al.
International Journal of STD & AIDS|December 20, 2013
Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in IsraelDaniel Elbirt, Ilan Asher, Keren Mahlev-Guri, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 23, 2011
Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with RitonavirKeren Mahlab-Guri, Ilan Asher, Serge Gradstein, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2018
The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patientsZev Sthoeger, Amir Sharabi, Ilan Asher, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 5, 2021
Characteristics of patients with spontaneous resolution of sesame allergyKeren Mahlab-Guri, Alex Guri, Laliv Kadar, et al.
Pageof 6